APINOFLOX-OZ Tablets: Dual-Action Combat Against Mixed Infections

APINOFLOX-OZ Tablets from MK Healthcare provide a potent, synergistic solution for treating a wide array of mixed bacterial and parasitic infections. This highly effective combination contains Ofloxacin (a fluoroquinolone antibiotic) and Ornidazole (an anti-protozoal and antibacterial agent). The dual-action formula is specifically designed to eliminate both aerobic bacteria and anaerobic organisms, making it a powerful tool for infections where single-drug therapy may be insufficient. It is commonly prescribed for various challenging conditions, including gastrointestinal infections (like acute diarrhea or dysentery), gynecological, and urinary tract infections.

Comprehensive Spectrum of Antimicrobial Activity

The strength of APINOFLOX-OZ lies in its two active components. Ofloxacin 200 mg works by inhibiting DNA gyrase, a critical enzyme that bacteria need to repair and replicate their genetic material, leading to bacterial death. Simultaneously, Ornidazole 500 mg damages the DNA of parasites and anaerobic bacteria, effectively killing these microorganisms. This combined mechanism ensures a broad-spectrum attack against infectious agents in complex sites, including the urinary tract, skin and soft tissue, respiratory system, and intra-abdominal areas, ensuring comprehensive infection control and preventing resistance development.

Trusted Quality for Gastrointestinal and Gynae Care

MK Healthcare's APINOFLOX-OZ tablets are manufactured under stringent ISO and GMP standards, guaranteeing a premium, reliable, and effective pharmaceutical solution for medical professionals. This combination is particularly valued in the treatment of diarrhea and dysentery caused by mixed infections, rapidly alleviating symptoms and supporting quicker patient recovery. The product?s efficacy in treating diverse infections, including those in the genital tract and those related to surgical procedures, makes it an essential medicine in the antibiotics and anti-infectives category.

Partnership Opportunities in the PCD Pharma Sector

For distributors and partners in the PCD Pharma Franchise sector, APINOFLOX-OZ is a high-demand product that commands respect in the anti-infective segment. MK Healthcare is committed to offering quality compositions like this Ofloxacin & Ornidazole Tablet combination at competitive prices. Leveraging this product in your portfolio allows you to address the critical need for effective treatment of both bacterial and parasitic ailments. Contact us today to discuss franchise terms, bulk purchasing, and product details for this crucial broad-spectrum antibiotic tablet.